The therapeutic effect of a combination of cofpropamine, a caffeine derivative, and cyclophosphamide on the development of adjuvant arthritis of rats and collagen arthritis of mice

General Pharmacology

Volumn 27, Issue 7, 1996, Pages 1215-1218

  Kroger, Hans ^a   Klosa, Josef ^b   Grätz, Regina ^c   Dietrich, Annette ^c   Ehrlich, Wilhelm ^c   Wild, Alfred ^d  

^a DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^b Robert Koc Institut ^*  (Germany)

^c ROBERT KOCH INSTITUTE   (Germany)

^d MERCK KGAA   (Germany)

Author keywords

adjuvant arthritis; cofpropamine; collagen arthritis; cyclophospamide

Indexed keywords

CAFFEINE DERIVATIVE; COFPROPAMINE; COLLAGEN TYPE 2; CYCLOPHOSPHAMIDE; FREUND ADJUVANT; UNCLASSIFIED DRUG;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ADJUVANT DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ALKYLATING AGENTS; ANIMALS; ARTHRITIS, EXPERIMENTAL; BODY WEIGHT; CAFFEINE; COLLAGEN; CYCLOPHOSPHAMIDE; DRUG SYNERGISM; ENZYME INHIBITORS; FOOT; JOINTS; MALE; MICE; MICE, INBRED DBA; POLY(ADP-RIBOSE) POLYMERASES; RATS; RATS, WISTAR;

EID: 0030273534     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00069-9     Document Type: Article

References (23)

1. Au W., Sokova O. I., Kopnin B. and Arrighi F. E. (1980) Cytogenetic toxicity of Cyclophosphamide and its metabolites in vitro. Cytogenet. Cell. Genet. 26, 108-116.
2. Arnold H., Bourseaux F. and Brock N. (1958) Chemotherapeutic action of a cyclic nitrogen mustard phosphamide ester in experimental tumors of the rat (B 518-ASTA). Nature 181, 931.
3. Berenbaum M. C. and Brown I. N. (1963) Prolongation of homograft survival in mice with a single dose of cyclophosphamide. Nature 200, 84.
4. Borek C., Morgan W. F., Ong A. and Cleaver J. E. (1984) Inhibition of malignant transformation in vitro by inhibitors of poly(ADP-ribose)synthesis. Proc. Natl. Acad. Sci. USA 81, 243-247.
5. Brock N., Gross R., Hokorst H. J., Klein, H. O. and Schneider B. (1971) Activation of cyclophosphamide in man and animals. Cancer 27, 1512-1529.
6. Elliott R. B. and Chase H. P. (1991) Prevention or delay of type 1 (insulin dependent) diabetes mellitus in children using nicotinamide. Diabetologia 34, 362-365.
7. Farzaneh F., Zalin R., Brill D. and Shall S. D. (1982) DNA strand breaks and ADP-ribosyl transferee acivation during cell transformation. Nature 300, 362-366.
8. Griffin R. J., Curtin N. J., Newell D. R., Golding B. T., Durkacz B. W. and Calvert A. H. (1995) The role of inhibitors of poly(ADP-ribose)polymerase as resistance-modifying agents in cancer therapy. Biochemie 77, 408-422.
9. Heller B., Wang Z. Q, Wagner E. F., Radons J., Bürkle A., Fehsel K., Burkart V. and Kolb H. (1995) Inactivation of the poly(ADP-ribose) polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells. J. Biol. Chem. 270, 11176-11180.
10. Kachel D. L. and Martin W. J. H. (1994) Cyclophosphamide induced lung toxicity; mechanism of endothelial cell injury. J. Pharmac. Exp. Ther. 268, 42-46.
11. Kröger H. and Klosa J. (1981). Carcinostatische Wirkung eines Coffein-8-Äther-Komplexes. Naturwissenschaften 68, 628.
12. Kröger H., Miesel R., Ehrlich W. and Kurpisz M. (1994) Arthritogenic mechanisms of deregulated poly-ADP-ribosylation in experimental models of arthritis. Z. Rheumatol. 53(suppl.), 59.
13. Kröger H. and Ehrlich W. (1994) The influence of tryptophan and nicotinamide on acetaminophenon hepatotoxicity in mice potentiated by ethanol and on adjuvans arthritis in rats. In L-Tryptophan: Current Prospects in Medicine and Drug Safety (Edited by Kochen W. and Steinhart H.), pp. 171-178. Walter de Gruyter, Berlin.
14. Lönn U. and Lönn S. (1985) Accumulation of 10 kilobase DNA replication intermediates in cells with 3-aminobenzamide. Proc. Natl. Acad. Sci. USA 82, 104-108.
15. Miesel R., Dietrich A., Ulbrich N., Kröger H. and Mitchison N. A. (1994) Assesment of collagen type II induced arthritis in mice by whole blood chemiluminescence. Autoimmunity 19, 153-159.
16. Mohr W., Wild A. and Beneke E. (1974) Chronische Osteomyelitis als Manifestation der Adjuvanskrankheit der Ratte. Beitr. Path. Bd. 153, 1-17.
17. Nudka N., Skidmore C.-J. and Shall C. (1980) The enhancement of cytotoxicity of N-methyl-N-nitrosurea and of γ-radiation by inhibitors of poly(ADP-ribose)polymerase. Eur. J. Biochem. 105, 525-530.
18. Oikawa A., Tohda H., Kanai M., Miwa M. and Sugimura T. (1980) Inhibitors of poly(adenosine diphosphate ribose)polymerase induce sister chromatide exchanges. Biochem. Biophys. Res. Commun. 97, 1311-1316.
19. Okamoto H., Takasawa S. and Tohgo A. (1995) New aspects of the physiological significance of NAD, poly ADP-ribose and cyclic ADP-ribose. Biochemie 77, 356-363.
20. Tseng A. Jr., Lee W. F. M., Kirsten E., Hakam A., McLick J., Bukir K. and Kun E. (1987) Prevention of tumorigenesis of oncogene-transformed rat fibroblasts with DNA-site inhibitors of poly(ADP-ribose) polymerase. Proc. Natl. Acad. Sci. USA 84, 1107-1111.
21. Ueda K. and Hayaishi O. (1985) ADP-ribosylation. Annu. Rev. Biochem. 54, 73-100.
22. Vaughan M. and Moss J. (1981) Mono (ADP-ribosyl)transferases and their effects on cellular metabolism. Curr. Top. Cell Regul. 20, 205-246.
23. Wooley P. H. (1988) Collagen-induced arthritis in the mouse. Meth. Enzymol. 162, 361-373.